News & Updates

Show Multimedia Only
Triple combination asthma inhaler works in patients with persistent airflow limitation

Triple combination asthma inhaler works in patients with persistent airflow limitation

17 Mar 2023

A novel once-a-day inhaler for asthma that contains a fixed-dose combination of the corticosteroid mometasone furoate (MF), the long-acting beta-agonist indacaterol acetate (IND), and the long-acting muscarinic antagonist glycopyrronium bromide (GLY) appears to have a favourable effect in patients with persistent airflow limitation (PAL), according to a post hoc analysis of the IRIDIUM study.

17 Mar 2023
Novel meningitis/encephalitis CSF testing shortens antiviral prescribing duration Novel meningitis/encephalitis CSF testing shortens antiviral prescribing duration

Novel meningitis/encephalitis CSF testing shortens antiviral prescribing duration

16 Mar 2023

The duration of antiviral prescribing has become much shorter with the introduction of the Biofire Filmarray meningitis/encephalitis (M/E) panel, a study has shown. However, its influence on antibiotic prescribing or health services in a paediatric hospital is minimal.

16 Mar 2023
C3 levels tied to incident T2DM; BMI plays a mediating role

C3 levels tied to incident T2DM; BMI plays a mediating role

16 Mar 2023

Complement C3 levels may be used as a predictor of incident type 2 diabetes mellitus (T2DM), suggests a study. In addition, body mass index (BMI) may have a mediating role in the association between C3 and T2DM, offering clues for diabetes pathogenesis.

16 Mar 2023